Daniel Dhumeaux

Daniel Dhumeaux's AcademicInfluence.com Rankings

Daniel Dhumeaux

Philosophy

#8038

World Rank

#11343

Historical Rank

Logic

#5073

World Rank

#6433

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Daniel Dhumeaux's Degrees

PhD Biomedical Sciences University of California, San Francisco
Doctorate Medicine Stanford University

Why Is Daniel Dhumeaux Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Daniel Dhumeaux's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. (2002) (6617)
Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C (2005) (1426)
Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. (2005) (569)
Immunological disorders in C virus chronic active hepatitis: A prospective case‐control study (1994) (516)
Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases (2006) (514)
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC (2006) (455)
Characteristics of patients with dual infection by hepatitis B and C viruses. (1998) (396)
Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. (1995) (378)
Diagnosis of Hepatic Fibrosis and Cirrhosis by Transient Elastography in HIV/Hepatitis C Virus-Coinfected Patients (2006) (364)
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: A pilot study (2002) (349)
Extrahepatic Immunologic Manifestations in Chronic Hepatitis C and Hepatitis C Virus Serotypes (1995) (335)
Epidemiological factors affecting the severity of hepatitis C virus‐related liver disease: A French survey of 6,664 patients (1997) (320)
Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies (2003) (316)
Management of focal nodular hyperplasia and hepatocellular adenoma in young women: A series of 41 patients with clinical, radiological, and pathological correlations (1995) (314)
Laparoscopic Liver Resection for Peripheral Hepatocellular Carcinoma in Patients With Chronic Liver Disease: Midterm Results and Perspectives (2006) (300)
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C (2005) (300)
Antiviral action of ribavirin in chronic hepatitis C. (2004) (273)
Oral contraceptive use and focal nodular hyperplasia of the liver. (2000) (220)
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma (2005) (216)
Interferon Resistance of Hepatitis C Virus Genotype 1b: Relationship to Nonstructural 5A Gene Quasispecies Mutations (1998) (215)
Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication (2002) (210)
Mechanism of phenobarbital-induced hypercholeresis in the rat. (1970) (198)
Standardization of Hepatitis C Virus RNA Quantification (2000) (186)
Lichen planus and hepatitis C virus--related chronic active hepatitis. (1994) (184)
Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture (1995) (184)
Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. (2014) (173)
Mechanisms and control of secretion of bile water and electrolytes. (1974) (170)
Ursodeoxycholic acid for primary sclerosing cholangitis. (1990) (163)
Effect of inhibitors of sodium transport on bile formation in the rabbit. (1970) (163)
Lack of mother‐to‐infant transmission of hepatitis C virus in human immunodeficiency virus–seronegative women: A prospective study with hepatitis C virus RNA testing (1993) (139)
Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis (2004) (138)
What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? (1998) (137)
Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. (1999) (137)
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. (1999) (131)
Association of focal nodular hyperplasia and hepatic hemangioma. (1989) (130)
Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro (2002) (128)
Impact of smoking on histological liver lesions in chronic hepatitis C (2003) (125)
Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway. (1995) (124)
Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study (2003) (122)
Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients (2002) (121)
Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. (1995) (115)
In vitro toxicity of polymorphonuclear neutrophils to rat hepatocytes: Evidence for a proteinase‐mediated mechanism (1988) (112)
Drug-induced vascular lesions of the liver. (1983) (110)
Hepatitis C virus in dermatology. A review. (1995) (109)
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C (1998) (109)
Mechanism of γ‐glutamyl transpeptidase release in serum during intrahepatic and extrahepatic cholestasis in the rat: A histochemical, biochemical and molecular approach (1990) (106)
Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial (1993) (105)
Effect of rifampicin on liver function in man (1972) (105)
Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections (2004) (104)
ORTHOTOPIC LIVER TRANSPLANTATION WITH PRESERVATION OF THE CAVAL AND PORTAL FLOWS Technique and Results in 62 Cases (1994) (104)
Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors. (1996) (103)
Factors Affecting Treatment Responses to Interferon-α in Chronic Hepatitis C (1996) (102)
Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. (1987) (94)
Dynamics of Hepatitis B Virus Resistance to Lamivudine (2006) (94)
Pulmonary Hypertension Complicating Portal Hypertension1, 2 (1979) (93)
Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. (2000) (90)
Histopathologic impact of GB virus C infection on chronic hepatitis C. (1997) (90)
Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay (1997) (90)
Evolution of the Hepatitis C Virus Second Envelope Protein Hypervariable Region in Chronically Infected Patients Receiving Alpha Interferon Therapy (1999) (89)
Treatment of hepatitis C. The 2002 French consensus (2003) (88)
Massive Blastic Infiltration of the Liver: A Cause of Fulminant Hepatic Failure (2007) (88)
Hepatitis C virus infection and autoimmune thrombocytopenic purpura. (1995) (88)
Pulmonary hypertension complicating portal hypertension. (1979) (87)
Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. (1977) (87)
High prevalence of hepatitis B, C, and E markers in young sexually active adults from The Central African Republic (1995) (86)
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation (1999) (85)
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay (1996) (85)
Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. (1999) (81)
Amiodarone‐induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease (1988) (80)
Hepatocellular adenoma: color Doppler US and pathologic correlations. (1994) (79)
Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study (1994) (79)
Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria (1987) (79)
Fibroblast growth factor 2 and transforming growth factor beta 1 interactions in human liver myofibroblasts. (1995) (78)
Hepatitis C Virus-Induced Hepatocellular Steatosis (2005) (78)
Efficacy and Safety of Two-Dose Regimens of Peginterferon Alpha-2a Compared with Interferon Alpha-2a in Chronic Hepatitis C: A Multicenter, Randomized Controlled Trial (2004) (76)
Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis: A clinical and immune-logical study of a series of 150 patients with primary biliary cirrhosis (1990) (75)
Antineoplastic agents and the liver (1980) (71)
Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. (1988) (70)
Antinuclear autoantibodies specific for lamins. Characterization and clinical significance. (1988) (67)
Oral contraceptive intake in women with focal nodular hyperplasia of the liver (1998) (67)
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141). (2014) (64)
Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy. (2002) (61)
Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users (2006) (60)
The impact of the prevention programme of hepatitis C over more than a decade: the French experience (2009) (60)
Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA (1994) (58)
Assessing the cost-effectiveness of hepatitis C screening strategies in France. (2018) (58)
Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? (2002) (57)
Autoantibodies to 200 kD polypeptide(s) of the nuclear envelope: a new serologic marker of primary biliary cirrhosis. (1988) (55)
The hot spot hepatobiliary scan in focal nodular hyperplasia. (1993) (55)
Orthotopic liver transplantation in the presence of partial or total portal vein thrombosis: Problems in diagnosis and management (1993) (54)
An outbreak of hepatitis B in an endocrinology unit traced to a capillary-blood-sampling device. (1990) (53)
MRI of atypical focal nodular hyperplasia of the liver: radiology-pathology correlation. (2004) (53)
Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver (1995) (53)
Lichen planus and hepatitis C virus (HCV)‐related chronic hepatitis: evaluation of HCV genotypes (1995) (51)
Vascular lesions of the liver in sickle cell disease. A clinicopathological study in 26 living patients. (1995) (51)
What technique should be used for routine detection and quantification of HBV DNA in clinical samples? (1997) (51)
SERIAL QUANTITATIVE DETERMINATION OF HEPATITIS C VIRUS RNA LEVELS AFTER LIVER TRANSPLANTATION A USEFUL TEST FOR DIAGNOSIS OF HEPATITIS C VIRUS REINFECTION (1995) (50)
The usefulness of microscopic bile examination in patients with suspected microlithiasis: A prospective evaluation (1986) (50)
Should we screen blood products for hepatitis E virus RNA ? (2014) (49)
Hepatic vein obstruction in idiopathic hypereosinophilic syndrome. (1985) (49)
Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity. (1987) (46)
Incidence of interferon alfa–induced depression in patients with chronic hepatitis C (2002) (45)
Peginterferon alpha‐2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha‐2b (2006) (45)
Oral contraceptives and the liver. (1972) (42)
Influence of hepatitis C virus (HCV) genotypes on HCV recombinant immunoblot assay patterns (1995) (41)
Antineoplastic agents and the liver. (1980) (40)
Chronic liver disease after low daily doses of amiodarone. Report of three cases. (1986) (39)
Low HCV replication levels in end-stage hepatitis C virus-related liver disease. (1999) (38)
The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region. (2007) (38)
Hepatitis B Vaccination in Diabetic Patients: Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen (1997) (37)
Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. (1996) (37)
Idiopathic biliary ductopenia in adults: a report of five cases. (1990) (36)
Lymphoproliferative disorder of donor origin in a liver transplant recipient: complete remission after drastic reduction of immunosuppression without graft loss. (1993) (36)
Cocaine and the liver. (1991) (36)
2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV (2016) (35)
Antiviral Activity of ANA773, an Oral Inducer of Endogenous Interferons that Acts Via TLR7, in Chronic Hepatitis C Patients (2011) (35)
Low‐grade steatosis and major changes in portal flow as new prognostic factors in steroid‐treated alcoholic hepatitis (2004) (35)
Ascitic fluid pH in alcoholic cirrhosis: a reevaluation of its use in the diagnosis of spontaneous bacterial peritonitis. (1985) (34)
Case Report: Terbinafine-Induced Prolonged Cholestasis with Reduction of Interlobular Bile Ducts (1997) (34)
Effect of simvastatin, an inhibitor of hydroxy‐methylglutaryl coenzyme a reductase, on the growth of human ito cells (1994) (33)
Chronic hyperbilirubinemia associated with hepatic uptake and storage impairment. A new syndrome resembling that of the mutant Southdown sheep. (1975) (33)
Hepatitis C Virus in Dermatology (1995) (33)
Hepatitis C Virus Quasispecies Variability Modulates Nonstructural Protein 5A Transcriptional Activation, Pointing to Cellular Compartmentalization of Virus-Host Interactions (2004) (32)
Hepatic handling of unconjugated dyes in the Dubin-Johnson syndrome. (1973) (32)
68 Daily cannabis smoking as a risk factor for fibrosis progression in chronic hepatitis C (2004) (32)
Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays. (1999) (31)
The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenic. (1996) (31)
A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C. (1996) (30)
Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C. (1995) (29)
Immunolocalization of heparinbinding growth factors (HBGF) types 1 and 2 in rat liver. Selective hyperexpression of HBGF‐2 in carbon tetrachloride‐induced fibrosis (1993) (29)
Hemochromatosis Cys282Tyr mutation and liver iron overload in patients with chronic active hepatitis C (1998) (29)
Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily. (2007) (29)
Evaluation of Liver Iron Content by Computed Tomography: Its Value in the Follow‐Up of Treatment in Patients with Idiopathic Hemochromatosis (2007) (28)
Effect on Bile Formation of Inhibitors of Sodium Transport (1969) (28)
Hepatic granulomas in Whipple's disease. (1984) (28)
[Nodular regenerative hyperplasia of the liver associated with azathioprine therapy]. (1991) (27)
Acute fatal hepatitis related to sertraline. (2001) (27)
Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding. (1984) (27)
Effects of rose bengal on bile secretion in the rabbit: inhibition of a bile salt-independent fraction (1970) (26)
[Prevalence of hepatitis C virus antibodies (tests ELISA 2 and RIBA 2) in a population of pregnant women in France]. (1992) (26)
Toxicity of phorbol myristate acetate-stimulated polymorphonuclear neutrophils against rat hepatocytes. Demonstration and mechanism. (1988) (26)
Cost‐effectiveness and budget impact of interferon‐free direct‐acting antiviral‐based regimens for hepatitis C treatment: the French case (2016) (26)
[Focal nodular hyperplasia and hepatocellular adenoma in women. Current data]. (1997) (26)
Spironolactone and enzyme induction in patients with alcoholic cirrhosis (1980) (25)
Chronic hepatitis C virus and gastric MALT lymphoma. (1998) (24)
Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis (1992) (24)
A critical study of the concept of maximal biliary transport of sulfobromophtalein (BSP) in the Wistar rat. (1970) (24)
GB virus C (GBV‐C) infection in patients with chronic hepatitis C. Influence on liver disease and on hepatitis virus behaviour: Effect of interferon alfa therapy (1998) (24)
Hepatitis C virus infection, mixed cryoglobulinemia, and B‐cell non‐Hodgkin's lymphoma (1999) (23)
Chronic hepatitis C after high‐dose intravenous immunoglobulin (1994) (22)
Reuse of a liver graft five days after initial transplantation. (1996) (22)
New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias (1978) (22)
Spontaneous portosystemic shunts in cirrhotics: implications for orthotopic liver transplantation. (1993) (22)
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis (2011) (21)
Reinforced interferon alpha‐2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial (2003) (20)
Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma (1995) (20)
Computer-aided selection of diagnostic tests in jaundiced patients. (1985) (20)
Biliary transport of cholephilic dyes: evidence for two different pathways. (1977) (20)
Effect of alpha interferon (IFN-alpha) on 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear cells of patients with chronic hepatitis C: relationship to the antiviral effect of IFN-alpha (1996) (20)
Anti-HCV seroprevalence in pregnant women in France. (1993) (20)
[Strategies of hepatitis C screening in general practice. Results of a two-center randomized trial]. (2000) (19)
Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent. (2012) (19)
Inhibitor against coagulation factor V after liver transplantation. (1999) (19)
Significance of anti‐hepatitis C virus core IgM antibodies in patients with chronic hepatitis C (1995) (18)
Hepatitis-associated antigen in human bile. (1971) (17)
Emergency hepatic arterial embolization for secondary hypercalcemia in hepatocellular carcinoma. (1979) (17)
Budd-Chiari syndrome and the lupus anticoagulant. (1985) (16)
[A rare cause of portal vein thrombosis: closed abdominal trauma]. (1994) (16)
Specificity of increased des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection. (1987) (16)
Virological and biochemical responses to interferon-α in chronic hepatitis C (1994) (16)
Copper and copper‐binding protein in liver tumors (1988) (16)
Type I membranoproliferative glomerulonephritis and HCV infection. (1996) (16)
Hepatitis C virus (HCV)-related cryoglobulinemia after liver transplantation for HCV cirrhosis (2002) (15)
[The effects of biliary drainage in cholestatic hepatitis]. (1970) (15)
49 LIFETIME COSTS ATTRIBUTABLE TO CHRONIC HEPATITIS C FROM THE FRENCH HEALTHCARE PERSPECTIVE (ANRS N°12188) (2013) (15)
Hepatitis C virus prevention and care for drug injectors: the French approach (2018) (15)
Measurement of hepatic blood flow in the rat. Trans-hepatic catheterization of the hepatic veins. (1973) (14)
Liver transplantation for fulminant hepatitis following chemotherapy for malignant lymphoma (1990) (14)
[Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases]. (1993) (14)
Mouse hepatic endothelial cells in culture secrete a growth inhibitor for hepatic lipocytes and Balb/c 3T3 fibroblasts. (1989) (13)
In vitro toxicity of hydrogen peroxide against normal vs. tumor rat hepatocytes: Role of catalase and of the glutathione redox cycle (1988) (13)
[Transmission of hepatitis C by accidental needlestick injuries. Evaluation of the risk]. (1994) (13)
[Prevalence of HBs antigen carriers and markers of B virus replication in a population of pregnant women, in France]. (1989) (12)
[Hepatocellular carcinoma without cirrhosis in a patient with nonalcoholic steatohepatitis]. (2004) (12)
A computer-aided system for the diagnosis of hepato-biliary diseases. A comparison with the performance of physicians. (1979) (12)
Role of bilirubin overproduction in revealing Gilbert's syndrome: is dyserythropoiesis an important factor? (1978) (12)
Dibromsulphalein (DBSP) Estimation of Hepatic Transport Function in Man * (1974) (11)
Inhibition of gastric alcohol dehydrogenase activity by histamine H2-receptor antagonists has no influence on the pharmacokinetics of ethanol after a moderate dose. (1994) (11)
[Hepatitis C virus infection. Epidemiology]. (1995) (11)
Chronic hepatic encephalopathy due to spontaneous splenorenal shunt: Successful treatment by transhepatic shunt embolization (1994) (11)
Epidemiologie et morbidité du virus de l'hépatite C en France : Etude de 6 664 patients atteints d'hépatite chronique C (1996) (10)
The application of computer techniques to the laboratory diagnosis. Diseases of the liver and biliary system. (1971) (10)
Unilobar small hepatic vein obstruction: Possible role of progestogen given as oral contraceptive (1983) (10)
[Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature]. (1983) (10)
Human liver plasma membrane Ca‐ATPase: Identification and sensitivity to calcium antagonists (1982) (9)
Upper respiratory and digestive tract malignancies after liver transplantation for alcoholic cirrhosis. (1996) (9)
Focal hemorrhagic necrosis of the liver. A clinicopathological entity possibly related to oral contraceptives. (1980) (9)
HEPATITIS-C VIRUS (HCV) GENOTYPE DETERMINATION - GENOTYPING VERSUS SEROTYPING (1995) (9)
Spironolactone and enzyme induction in patients with alcoholic cirrhosis. (1980) (9)
Chemoembolization for hepatocellular carcinoma in cirrhotic patients: assessment of efficacy on total hepatectomy specimens. (1994) (9)
Effects of propranolol on pulmonary gas exchange in patients with cirrhosis. (1989) (9)
Hereditary conjugated hyperbilirubinaemia: 37 years later. (2013) (9)
Measurement of gastric intramucosal pH in patients with cirrhosis and portal hypertensive gastropathy. (1994) (9)
Hepatic calcification due to Fasciola gigantica. (1974) (9)
Focal hemorrhagic necrosis of the liver: A clinicopathological entity possibly related to oral contraceptives (1980) (9)
Demonstration of a basic fibroblast growth factor-like molecule in mouse hepatic endothelial cells. (1989) (9)
Worsening of steatosis and fibrosis progression in hepatitis C (2003) (8)
Coagulation Assays as Diagnostic Markers of Hepatocellular Carcinoma (1988) (8)
Review article: HCV ? STAT-C era of therapy (2010) (8)
Pharmacokinetics and bioavailability of ranitidine in normal subjects and cirrhotic patients (1986) (8)
Noradrenalin for treatment of type I hepatorenal syndrome (HRS) (2001) (8)
[Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine]. (1986) (8)
[Do general practitioners want to manage chronic hepatitis C and take part in hepatitis C health networks? A national survey]. (1999) (8)
Significance of NS5‐“indeterminate” third‐generation anti‐hepatitis C virus serologic assays (1995) (8)
[Non-A non-B, type C hepatitis]. (1990) (8)
High-dose cyclosporine A induction therapy in liver transplant recipients with normal postoperative renal function: a prospective study. (1995) (8)
Lichen planus, chronic hepatitis C, and interferon (1995) (8)
Cystic dilatation of intrahepatic bile ducts in primary sclerosing cholangitis. (1990) (7)
SERUM ANTIBODIES AGAINST DOUBLE-STRANDED DNA IN CHRONIC ACTIVE HEPATITIS: AN INDEX OF DRUG-INDUCED LIVER DISEASE? (1983) (7)
O85 SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188) (2014) (7)
Constitution rapide de calcifications intra-hépatiques au décours d'un syndrome HELLP (2002) (7)
62 Is ribavirin antiviral effect in humans mediated by mutagenic properties resulting in error catastrophe (2004) (7)
[Hepatic transplantation for severe ductopenia related to ingestion of thiabendazole]. (1997) (7)
[Chronic active hepatitis associated with anti-native DNA antibodies: incidence of drug etiology]. (1984) (7)
Amiodarone-induced liver disease. (1989) (7)
Nicardipine as antihypertensive therapy in liver transplant recipients: Results of long‐term use (1997) (7)
[Chronic lesion of the interlobular bile ducts induced by fenofibrate]. (1994) (6)
[Treatment of viral hepatitis C]. (1994) (6)
Increased Gastric Bicarbonate Secretion in Portal Hypertensive Anesthetized Rats (Role of Prostaglandins and Nitric Oxide) (1997) (6)
Hemochromatosis C282Y mutation and histological fibrosis in patients with C virus chronic hepatitis (1999) (6)
[Hepatitis C in France]. (2002) (6)
Unilobar small hepatic vein obstruction: possible role of progestogen given as oral contraceptive. (1983) (6)
Unusual hepatic venous drainage in inferior vena cava obstruction: demonstration by MRI. (1986) (6)
[Chenodeoxycholic acid treatment of gallstones: a survey of 25 patients (author's transl)]. (1978) (6)
[Non-A, non-B viral hepatitis]. (1984) (6)
Effect of phenobarbital in a case of extrahepatic cholestasis. (1975) (6)
P.228 Assessment of ribavirin mutagenic properties in vivo and the influence of interferon alpha-induced reduction of hepatitis C virus RNA load upon therapy (2006) (6)
Characterization of two human monoclonal IgM antibodies that recognize nuclear lamins (1992) (6)
[Congenital cystic diseases of the intra and extrahepatic bile ducts]. (2005) (6)
[Comparison of the effects of cimetidine and ranitidine in vivo and in vitro on the hepatic microsomal enzyme system in rats]. (1983) (5)
[Assessment of hepatic fibrosis: what is the role of non-invasive markers in 2003?]. (2003) (5)
Trends of hepatitis C screening in France through Rena-VHC and hepatology reference centres surveillance systems, 2000-2007. (2009) (5)
AASLD AbstractAre hepatitis C virus genotypes 1a and 1b so diffrent (1995) (5)
CONSTITUTIONAL UNCONJUGATED HYPERBILIRUBINÆMIA (1977) (5)
Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: Evidence for a role of HCV genotype 3 in steatosis (2003) (5)
[The liver and vitamin A]. (1985) (5)
Are hepatitis C virus genotypes 1a and 1b so different? (1996) (5)
Fracture of biliary endoprosthesis after endoscopic drainage for malignant biliary obstruction. Report of two cases. (1986) (4)
Toxicity of polymorphonuclear neutrophils against hepatocytes: protective effect of heparin. (1989) (4)
Other clinical studyHuman myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver (1995) (4)
[Hepatic resection for Caroli's disease limited to the left liver. Fortuitous disclosure of cholangiocarcinoma]. (1983) (4)
Is the detection of anti‐hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor? (1995) (4)
Histological evaluation of alpha 2a interferon monotherapy in patients with chronic hepatitis C and repeatedly normal aminotransferase levels. A randomized study (2001) (4)
Diagnosis of HCV recurrence after liver transplantation using branched DNA assay for HCV RNA quantitation. (1994) (4)
Hepatitis C virus NS3 serine protease variability and evolution are strongly constrained by the need for structural and functional conservation (2002) (4)
SALIVARY-GLAND LESIONS IN PATIENTS WITH CHRONIC HEPATITIS-C (1994) (4)
Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alfa efficacy in chronic hepatitis C: A wrong track (2000) (4)
Should the patients with histologically mild chronic hepatitis C betreated (2000) (4)
[Treatment of hepatitis C: advances and consensus]. (2002) (3)
[Fast appearance of intra-hepatic calcifications following a case of HELLP syndrome]. (2002) (3)
Factors associated with recurrence after transplantation for hepatocellular carcinoma (2003) (3)
[Hepatic fibrosis and portal hypertension in chronic vitamin A poisoning]. (1984) (3)
[Clinical symptomatology and radiological aspects of primary cancers of the liver]. (1992) (3)
[Anti-mitochondria antibodies with an anti-M aspect, in Q fever]. (1984) (3)
Decreased toxicity of polymorphonuclear neutrophils toward hepatocytes isolated from rats with acute inflammatory reaction (1990) (3)
[Prevalence of hepatitis C virus infection in pregnant woman on the island of Réunion]. (1999) (3)
Hepatitis B infection: estimation of the annual number of newly infected cases in France, 2004-2007. (2009) (3)
Alpha 2A interferon monotherapy in patients with chronic hepatitis C and repeatedly normal aminotransferase levels (2000) (3)
Serum anti-liver cytosol antibodies type 1 in hepatitis C virus infection. (1994) (3)
[Tienilic acid can induce acute hepatitis, chronic hepatitis and cirrhosis. A report of three cases (author's transl)]. (1981) (3)
A French consensus conference on hepatitis C: screening and treatment. (1997) (3)
Prediction of survival after liver transplantation (LT) for hepatocellular carcinoma (HCC) using the TNM staging classification modified for LT: Validation in a French cohort (2003) (3)
[Auxiliary hepatic transplantation in iproniazid-induced subfulminant hepatitis. Should iproniazid still be sold in France?]. (1999) (3)
[Double liver-kidney transplantation in the presence of a positive T cross-match]. (1992) (3)
809 IMMEDIATE OR DELAYED TREATMENT INITIATION WITH “PREVIR” CONTAINING REGIMENS IN HCV-INFECTED NAIVE GENOTYPE 1 (G1) PATIENTS WITHOUT SEVERE FIBROSIS? A COST-EFFECTIVENESS ANALYSIS (ANRS N°12188) (2013) (2)
Liver diseases associated with autoantibodies directed to nuclear envelope components (1989) (2)
1362 THE AVAILABILITY OF DIRECT ACTING ANTIVIRALS (DAA) IN 2012: A FRENCH MODEL-BASED ANALYSIS OF THE INCREASED NUMBER OF PATIENTS TREATED FOR CHRONIC HCV INFECTION (2011) (2)
Constitutional unconjugated hyperbilirubinaemia. (1977) (2)
605 Viral steatosis is not related to fibrosis severity in patients with chronic hepatitis C (2003) (2)
Liver iron overload in patients with chronic active hepatitis C. Prevalence, role of the hemochromatosis gene and relation with hepatic histological lesions (1998) (2)
[2 cases of cirrhosis in patients treated with amiodarone]. (1985) (2)
[Hepatic cholesterol ester storage disease. Two new cases diagnosed in adults]. (1991) (2)
[Iron overload and liver diseases (except for hemochromatosis and dysmetabolic hepatosiderosis]. (2000) (2)
[Nuclear envelope autoantibodies and liver diseases]. (1990) (2)
[Chronic active hepatitis]. (1995) (2)
The thymol turbidity test and determination of serum cholesterol : two tests to abandon in the routine evaluation of liver function. (1978) (2)
Factor predictive of a response to interferrcn cherapy in NANB chronic active hepatitis (1990) (2)
Pentoxifylline inhibits the proliferation and the fibrogenic properties of human hepatic myofibroblastic cells (1995) (2)
[Biliary secretion of rabbit: evidence in favor of important fraction independent of bile salts]. (1969) (2)
Post-transplant lymphoproliferative disorders (PTLD) after liver transplantation (LT). Role of HCV infection (1998) (1)
Hepatitis C virus (HCV)‐related cryoglobulinemia after liver transplantation for HCV cirrhosis (2002) (1)
Congenital Erythropoietin-Dependent Erythrocytosis Responsive to Theophylline Treatment (1998) (1)
Use of denatuning gradient gel electrophoress (DGGE) for studying the gentic variability of hepattits B virus (1990) (1)
[Microvacuolar steatosis following low doses of doxycycline]. (2002) (1)
634 Assessment of biliary fibrosis by transient elastography in PBC and PSC patients (2006) (1)
[Hepatitis C virus ten years after its discovery]. (1999) (1)
[Diagnosis of cholestasis]. (1982) (1)
Non virological factors associated with fibrosis progression after hepatitis C virus (HCV) graft reinfection (2002) (1)
[The G virus: the orphan virus]. (1999) (1)
Alcohol intake, even moderate, induces increased histological activity and fibrosis in patients with chronic active hepatitis C (1998) (1)
Prognostic factors associated with liver transplantation (LT) for hepatocellular carcinoma (HCC) (2001) (1)
Survival benefit associated with liver transplantation (LT) in patients transplanted for hepatocellular carcinoma (HCC) (2001) (1)
Are basal core-IgM antibodies to hepatitis C virus predictive of successful alpha-interferon therapy? (1995) (1)
Tampon use as a cause of recurrent cholestatic jaundice. (1982) (1)
Is ursodeoxycholic acid an effective treatment for primary sclerosing cholangitis (1989) (1)
[The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)]. (1978) (1)
Clinical significance of HCV core antigen, a new marker of HCV infection (2002) (1)
[ The mobilization of an entire discipline around a white book: why?]. (2001) (1)
1150 Dynamics and early diagnosis of HBV resistance to lamivudine: a thorough quasispecies analysis (2003) (1)
[Treatment of chronic hepatitis C: present and future]. (2000) (1)
[Oxyphenisatin, a laxative responsible for chronic hepatitis and cirrhosis, still marketed in France (author's transl)]. (1979) (1)
[Non-A non-B acute hepatitis]. (1990) (1)
[Acarbose-induced acute hepatitis]. (1999) (1)
Special Issue - Surveillance and prevention of hepatitis B and C in France: assessment and prospects. (2009) (1)
Acute inflammatory reaction promotes resistance of hepatocytes to polymorphonuclear cell toxicity (1989) (1)
[Vigabatrin-induced cytolytic hepatitis]. (2001) (1)
Myasthenia gravis and hepatitis C virus infection (1994) (1)
Ascitic fluid pHinalcoholic cirrhosis: areevaluation of its useinthediagnosis ofspontaneous bacterial peritonitis JSCEMAMA-CLERGUE,C DOUTRELLOT-PHILIPPON, J-MMETREAU, (1985) (1)
[Effect of spironolactone on bile formation and liver microsomal enzymic activities in the rat (author's transl)]. (1977) (1)
[Steasis and hepatitis C]. (2003) (0)
[Tomodensitometry of the liver and biliary tracts]. (1980) (0)
Gastric malt lymphoma : a pathogenetic role of hepatitis C virus (HCV)? (1998) (0)
Study on the risk perception of viral hepatitis B and its vaccine prevention among people consulting in a free and anonymous screening centre (CDAG), 2007, Paris, France. (2009) (0)
Are there risk factors other than genotype associated to hepatitis Cvirus (HCV) recurrence after liver transplantation (LT) (2000) (0)
Steatosis is associated with worse histological activity and fibrosis in patients with chronic hepatitis C (2001) (0)
Congenital abnormalities of the biliary tract (2012) (0)
[Nonconjugated hyperbilirubinemia of drug origin and hepatic glucuro-conjugation]. (1971) (0)
Evolution of risk factors and characteristics of patients with chronic hepatitis C between 1990 and 1997 in an urban area in France (1998) (0)
Adjuvant chemotherapy and radiotherapy in liver transplantation for primary hepatocellular carcinoma: a feasibility study (1994) (0)
[Reticulosarcoma of the small intestine revealed by malabsorption syndrome]. (1970) (0)
Overt B-cell non-Hodgkin's lymphoma (B-NHL): Role of hepatitis C virus (HCV) (2000) (0)
Detection of hepatic injury in multiple trauma (1976) (0)
[Diagnostic difficulties in a case of visceral leishmaniasis observed in Paris. Hepatic manifestations of visceral leishmaniasis]. (1970) (0)
Evaluation de la fibrose hépatique (2008) (0)
A basic fibroblast growth factor-like molecule synthetized by hepatic sinusoidal endothelial cells may regulate Ito cell proliferation (1989) (0)
[Iron and chronic liver disease (excluding genetic hemochromatosis and metabolic liver siderosis)]. (2000) (0)
Prolifération lymphocytaire et virus de l'hépatite C (1999) (0)
Gastric malt lymphoma: Pathogenetic role of hepatitis C virus (1998) (0)
[The role of virologic tests in the treatment of chronic hepatitis C]. (1999) (0)
[Acanthocytosis in cirrhosis. Report of four cases and review of the literature (author's transl)]. (1977) (0)
[Biliary calcinosis and fibrous dystrophy of the neck of the gallbladder in a 29-year-old man]. (1996) (0)
Evaluation of liver iron content by computerized tomography its interest for the follow up of treated patients with idiopathic hemo chromatosis (1982) (0)
Steatosis, fibrosis and hepatitis C virus infection (2010) (0)
[Pegylated interferons: pharmacological basis]. (2002) (0)
Hepatitis Cvirus infection can mimictype1 (antinuclear antibody positive) autoimmune (1993) (0)
Dibromsulphalein (DBSP) Estimation of Hepatic Transport Function in Man * (1974) (0)
[Hepatic glucurono-conjugation of phthaleins. Study in the Wistar rat and the homozygous Gunn rat]. (1968) (0)
Newinsights into theclassification andmechanisms ofhereditary, chronic, non-haemolytic hyperbilirubinae (1978) (0)
Hepatitis C virus iukction and autoimnune thrornbocytope& purpura (1995) (0)
1189 Mechanisms of ribavirin early antiviral effect in chronic hepatitis C: is it related to ribavirin mutagenic properties inducing? Error catastrophe? (2003) (0)
Does HCV core antigen detection in graft donors improve organ transplantation viral safety (2001) (0)
[Severe hepatitis caused by phenobarbital]. (1994) (0)
Virological and biochemical responses to interferon-alpha in chronic hepatitis C. (1994) (0)
An outbreak of B virus hepatitis in diabetic patients. Role of an automatic device used for glucose estimations (1989) (0)
[Chronic hepatitis C with repeatedly normal transaminase levels]. (2002) (0)
[Chronic viral hepatitis B and C. Epidemiology, diagnosis, etiology, prevention]. (2001) (0)
[Primary biliary cirrhosis and Biermer's anemia]. (1980) (0)
P1227 : Intra-hepatic Cholestasis of Pregnancy (ICP): Prevention of recurrence of ICP and intra uterine fetal death by pre-pruritus administration of ursodeoxycholic acid (2015) (0)
[Which precautions should be taken in case of hepatitis C? From the statement of the question to the dissemination of the response in a consensus conference]. (1998) (0)
genotyping assay . genotype : comparison with a standardized Serological determination of hepatitis C virus (1997) (0)
[Biological and clinical study of diffuse atrophy of the small intestine]. (1967) (0)
P.203 Colocalization of HCV core protein with intracellular lipid droplets occurs regardless of the HCV genotype and the steatogenic character of HCV strains (2006) (0)
Effect ofrifampicin on liver function inman (1972) (0)
Dynamics of lamivudine-resistant HBV mutants: a quasispecies analysis (2002) (0)
Gamma-glutamyltranspeptidase in cholestasis. An histochemical, biochemical and molecular approach using two experimental models (1989) (0)
[Towards early screening and treatment of hepatocellular carcinoma cirrhosis?]. (2002) (0)
Functional consequences of HCV quasispecies distribution: transcriptional activation by HCV non structural 5A (NS5A) protein is quasispecies-dependant (2001) (0)
Antinuclear Autoantibodies Specific for Lamins (2020) (0)
Factors associated with steatosis and relationship between steatosis and the severety of the disease in patients with chronic hepatitis C (2002) (0)
Mixed cryoglobulinemia after liver transplantation (LT) for HCV cirrhosis. Prevalence and features (1998) (0)
Can histological factors predict evolution towards severe fibrosis in recurrent hepatitis C after liver transplantation (2001) (0)
[The treatment of viral hepatitis]. (1991) (0)
Non-structural 5A (NS5A) protein and HCV genotype 3a sensitivity to interferon (IFN)-alpha therapy (2001) (0)
Subject Index, Vol. 7, 1972 (1972) (0)
SPECIFICITY OF INCREASED DES-GAMMA-CARBOXYPROTHROMBIN AS A MARKER OF HEPATOCELLULAR CARCINOMA AFTER VITAMIN K INJECTION (1987) (0)
HCV genotype 1 resistance to interferon (IFN) afla antiviral effect: Role of the nonstructural NS5A protein and the putative ISDR (2003) (0)
Steatosis evolution is a main determinant of fibrosis progression in untreated patients with chronic hepatitis C (2002) (0)
[Drug-induced chronic hepatitis and cirrhosis]. (1993) (0)
Maximal biliary transport of sulfobromophthalein in the Wistar rat. A critical study. (1971) (0)
Dynamic quasispecies analysis of YMDD mutants in patients with chronic hepatitis B resistant to lamivudine (2003) (0)
[Infected ascites in the cirrhotic patient: toward prevention?]. (1987) (0)
Prevalence and prognostic significance of portal blood flow reversionin severe steroid-treated alcoholic hepatitis (2000) (0)
[Comparative study of pinocytosis and the production of prostaglandin E2 by hepatic and peritoneal resident macrophages in mice]. (1985) (0)
483 Metabolic, but not virus-induced steatosis, is related with liver disease severity in chronic hepatitis C (2004) (0)
Steroid withdrawal in cyclosporin a (CSA)-treated liver transplant(LT) recipients. Pathological and biochemical assessment (2000) (0)
419 Hepatitis C virus genotype 3, but not genotype 1, is cytopathic, steatogenic (2003) (0)
[Prion diseases, the liver and the digestive system]. (1999) (0)
Authors’ Index, Vol. 7, 1972 (1972) (0)
117 Liver transplantation for hepatocellular carcinoma: A new prognostic score predicting disease-free survival (2004) (0)
[Severe hepato-cellular insufficiency and renal insufficiency in a 66-year-old woman]. (1980) (0)
[Hepatitis B. Epidemiology, etiology, diagnosis, development, prognosis, principles of treatment]. (1992) (0)
Effect of tobacco consumption on hepatic histological lesions in patients with chronic hepatitis C (2000) (0)
Contents, Vol. 7, 1972 (1972) (0)
[Epidemiology of hepatitis C in France: from transfusion to drug addiction]. (1994) (0)
[Thrombosis of the smaller hepatic veins. Diagnostic value of retrograde hepatic phlebography]. (1972) (0)
[Results of and indications for chenodesoxycholic acid in vesicular lithiasis (proceedings)]. (1977) (0)
Cost-Effectiveness and Budget Impact of Interferon-Free Direct-Acting Antiviral (DAA)-Based Regimens for Chronic Hepatitis C Treatment. The French Case (2016) (0)
The majority of liver transplant recipients with normal liver enzymetests (LET) exhibit long term liver graft lesions (2000) (0)
[Mechanisms of drug-induced hepatitis]. (1990) (0)
Relationship between steatosis and fibrosis in chronic hepatitis C: Effect of HCV genotype (2003) (0)
Perception and knowledge of virral hepatitis: results of the Nicolle Survey, France, 2006. (2009) (0)
[Clinical hepatology at the dawn of the year 2000]. (2000) (0)
[Results of the treatment with biliary dissolvents]. (1992) (0)
Are there risk factors other than genotype associated to hepatitis C virus (HCV) recurrence after liver transplantation (LT) (2000) (0)
Reply: (2007) (0)
[Detection of hepatic lesions in patients with multiple injuries. Value of the determination of blood glutamo-pyruvic transaminase]. (1975) (0)
Initial clinical patterns of hepatitis C virus reinfection after liver transplantation for hepatitis C virus-related cirrhosis. (1996) (0)
[Diagnostic value and meaning of radiocopper loading test abnormalities in Wilson's disease (author's transl)]. (1982) (0)
Compensated viral cirrhosis: descriptive analysis of 774 first patients included in a prospective French cohort (ANRS CO12 CirVir). (2009) (0)
Representations of hepatitis C treatment among drug users. InVS-ANRS Coquelicot Survey, France, 2004-2007. (2009) (0)
[Hepatitis during treatment with ketoconazole]. (1984) (0)
[Diagnosis with a computer. Preliminary results of an application to liver diseases and bile duct diseases]. (1970) (0)
Edinburgh Research Explorer Serological determination of hepatitis C virus genotype (1997) (0)
First International Gstaad Symposium: The Liver Quantitative Aspects of Structure and Function (1972) (0)
[Treatment of chronic hepatitis C]. (1995) (0)
[Jaundice and rifampicin. Critical study]. (1974) (0)
Acute inflaxxatory reaction protects against corynebacterium parvum/endotoxin-induced hepatitis (1990) (0)
585 Major changes in portal blood flow and low grade steatosis as new pronostic factors in corticosteroid treated patients with alcoholic hepatitis (2004) (0)
The majority of liver transplant recipients with normal liver enzyme tests (LET) exhibit long term liver graft lesions (2000) (0)

This paper list is powered by the following services:

Daniel Dhumeaux's Academic­Influence.com Rankings

Daniel Dhumeaux's Degrees

Why Is Daniel Dhumeaux Influential?

Daniel Dhumeaux's Published Works

Published Works

Daniel Dhumeaux's AcademicInfluence.com Rankings